952 related articles for article (PubMed ID: 30213237)
1. Excessive release of endogenous neuropeptide Y into cerebrospinal fluid after treatment of spontaneous subarachnoid haemorrhage and its possible impact on self-reported neuropsychological performance - results of a prospective clinical pilot study on good-grade patients.
Bründl E; Proescholdt M; Schödel P; Bele S; Höhne J; Zeman F; Stoerr EM; Brawanski A; Schebesch KM
Neurol Res; 2018 Dec; 40(12):1001-1013. PubMed ID: 30213237
[TBL] [Abstract][Full Text] [Related]
2. Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage-a feasibility series.
Bründl E; Proescholdt M; Störr EM; Schödel P; Bele S; Höhne J; Zeman F; Brawanski A; Schebesch KM
Neurosurg Rev; 2021 Jun; 44(3):1479-1492. PubMed ID: 32572710
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Spontaneous Subarachnoid Hemorrhage and Self-Reported Neuropsychological Performance at 6 Months - Results of a Prospective Clinical Pilot Study on Good-Grade Patients.
Bründl E; Schödel P; Bele S; Proescholdt M; Scheitzach J; Zeman F; Brawanski A; Schebesch KM
Turk Neurosurg; 2018; 28(3):369-388. PubMed ID: 29204979
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Schebesch KM; Brawanski A; Bele S; Schödel P; Herbst A; Bründl E; Kagerbauer SM; Martin J; Lohmeier A; Stoerr EM; Proescholdt M
Neurol Res; 2013 Dec; 35(10):1038-43. PubMed ID: 23915659
[TBL] [Abstract][Full Text] [Related]
5. The endogenous neuropeptide calcitonin gene-related peptide after spontaneous subarachnoid hemorrhage-A potential psychoactive prognostic serum biomarker of pain-associated neuropsychological symptoms.
Bründl E; Proescholdt M; Störr EM; Schödel P; Bele S; Zeman F; Hohenberger C; Kieninger M; Schmidt NO; Schebesch KM
Front Neurol; 2022; 13():889213. PubMed ID: 35968282
[TBL] [Abstract][Full Text] [Related]
6. Differences in Neuropeptide Y Secretion Between Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage.
Schebesch KM; Bründl E; Schödel P; Hochreiter A; Scheitzach J; Bele S; Brawanski A; Störr EM; Lohmeier A; Proescholdt M
J Neurosurg Anesthesiol; 2017 Jul; 29(3):312-316. PubMed ID: 27438796
[TBL] [Abstract][Full Text] [Related]
7. The possible role of neuropeptide Y after spontaneous subarachnoid hemorrhage.
Schebesch KM; Brawanski A; Kagerbauer SM; Martin J; Bele S; Herbst A; Feigl G; Stoerr EM; Lohmeier A; Proescholdt M
Acta Neurochir (Wien); 2011 Aug; 153(8):1663-8; discussion 1668. PubMed ID: 21626172
[TBL] [Abstract][Full Text] [Related]
8. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
9. Both coiling and clipping induce the time-dependent release of endogenous neuropeptide Y into serum.
Bründl E; Proescholdt M; Schödel P; Rosengarth K; Störr EM; Bele S; Kieninger M; Malsy M; Schmidt NO; Schebesch KM
Front Neurol; 2023; 14():1325950. PubMed ID: 38425753
[TBL] [Abstract][Full Text] [Related]
10. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article.
Fountas KN; Tasiou A; Kapsalaki EZ; Paterakis KN; Grigorian AA; Lee GP; Robinson JS
Neurosurg Focus; 2009 May; 26(5):E22. PubMed ID: 19409001
[TBL] [Abstract][Full Text] [Related]
11. Early permanent cerebrospinal fluid diversion in aneurysmal subarachnoid hemorrhage: does a lower rate of nosocomial meningitis outweigh the risk of delayed cerebral vasospasm related morbidity?
Croci DM; Dalolio M; Aghlmandi S; Taub E; Rychen J; Chiappini A; Zumofen D; Guzman R; Mariani L; Roethlisberger M
Neurol Res; 2021 Jan; 43(1):40-53. PubMed ID: 33106124
[No Abstract] [Full Text] [Related]
12. Calcitonin-gene related peptide and cerebral vasospasm.
Schebesch KM; Herbst A; Bele S; Schödel P; Brawanski A; Stoerr EM; Lohmeier A; Kagerbauer SM; Martin J; Proescholdt M
J Clin Neurosci; 2013 Apr; 20(4):584-6. PubMed ID: 23313519
[TBL] [Abstract][Full Text] [Related]
13. S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction.
Hårdemark HG; Almqvist O; Johansson T; Påhlman S; Persson L
Acta Neurochir (Wien); 1989; 99(3-4):135-44. PubMed ID: 2788973
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid lactate and neurological outcome after subarachnoid haemorrhage.
Lindgren C; Koskinen LO; Ssozi R; Naredi S
J Clin Neurosci; 2019 Feb; 60():63-67. PubMed ID: 30361053
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous subarachnoid hemorrhage of unknown origin: hospital course and long-term clinical and angiographic follow-up.
Elhadi AM; Zabramski JM; Almefty KK; Mendes GA; Nakaji P; McDougall CG; Albuquerque FC; Preul MC; Spetzler RF
J Neurosurg; 2015 Mar; 122(3):663-70. PubMed ID: 25526276
[TBL] [Abstract][Full Text] [Related]
16. Non-aneurysmal non-perimesencephalic subarachnoid hemorrhage: effect of rehabilitation at short-term and in a prospective study of long-term follow-up.
Konczalla J; Schmitz J; Kashefiolasl S; Senft C; Platz J; Seifert V
Top Stroke Rehabil; 2016 Aug; 23(4):261-8. PubMed ID: 26916565
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of initial clinical status, intracranial pressure and transcranial Doppler pulsatility after subarachnoid haemorrhage.
Soehle M; Chatfield DA; Czosnyka M; Kirkpatrick PJ
Acta Neurochir (Wien); 2007 Jun; 149(6):575-83. PubMed ID: 17460816
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of cerebral perfusion 1 week after haemorrhage is an independent predictor of clinical outcome in patients with aneurysmal subarachnoid haemorrhage.
Mustonen T; Koivisto T; Vanninen R; Hänninen T; Vapalahti M; Hernesniemi J; Kuikka JT; Vanninen E
J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1128-33. PubMed ID: 18356250
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y in the primate model of subarachnoid hemorrhage.
Pluta RM; Deka-Starosta A; Zauner A; Morgan JK; Muraszko KM; Oldfield EH
J Neurosurg; 1992 Sep; 77(3):417-23. PubMed ID: 1506889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
